Drug Substance Manufacturing: Steps, Challenges & CDMO Solutions
Producing the Active Pharmaceutical Ingredient (API) is one of the most complex stages in pharmaceutical development. Minor errors in process design, scale-up, or quality control can cause delays, regulatory setbacks, or supply interruptions. By implementing robust drug substance manufacturing practises, organisations can ensure each batch meets critical quality standards, remains consistent at scale, and aligns […]